http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2447867-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6379feda6e2eb9af0653088fc5870448
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-08
filingDate 2010-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f549b748ddf31b3c9ffe0d7be168858d
publicationDate 2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2447867-C1
titleOfInvention Method of treating squint with atypical innervation of extraocular muscles
abstract FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely ophthalmology and may be used to treating spastic squint and atypincal squint accompanying type 1 Duane syndrome. It involves exposing a lateral end of an internal rectus muscle, further at 2-3 mm from an attachment point of the muscle to sclera a needle is inserted in an end face of the lateral muscle; the needle is moved at 8-10 mm along the muscle in a distal direction at an angle from the lateral end of the muscle to its middle axial border, and the preparation Disport 15-20 units is introduced. The incisional wound is closed. The similar method is used for surgical manipulations on the internal rectus muscle of the other eye, if the patient suffers from spastic squint and double Duane syndrome. n EFFECT: method provides reduced dynamometric functions of the internal rectus muscles and compensated optimal balance in the oculogyric system. n 2 dwg, 2 ex
priorityDate 2010-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2257914-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450497080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502098

Total number of triples: 18.